These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15411637)

  • 21. Fatal hepatorenal syndrome associated with phenurone therapy.
    LEVY RW; SIMONS DJ; ARONSON S
    N Engl J Med; 1950 Jun; 242(24):933-6. PubMed ID: 15423683
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatal aplastic anemia occurring during anticonvulsant therapy: probable idiosyncrasy to phenurone.
    SIMPSON TW; WILSON EB; ZIMMERMAN SL
    Ann Intern Med; 1950 Jun; 32(6):1224-8. PubMed ID: 15419613
    [No Abstract]   [Full Text] [Related]  

  • 23. [PHARMACOLOGICAL STUDIES ON PHENYLCARBAMIDE DERIVATIVES WITH SPECIAL REFERENCE TO THE RELATION OF THEIR CHEMICAL STRUCTURE TO ANTICONVULSANT PROPERTIES. II. COMPARATIVE STUDIES ON PHENYLCARBAMIDE, META-TOLYCARBAMIDE AND PHENURONE].
    RUSINOV K; GEORGIEV V
    Izv Inst Fiziol (Sofiia); 1964; 7():123-32. PubMed ID: 14335492
    [No Abstract]   [Full Text] [Related]  

  • 24. ON CERTAIN CORRELATIONS OF THE ANTICONVULSIVE DRUGS PHENYLCARBAMIDE, META-TOLYLCARBAMIDE AND PHENURONE WITH CHOLINERGIC AND ADRENERGIC MECHANISMS IN THE CENTRAL NERVOUS SYSTEM.
    ROUSSINOV K
    C R Acad Bulg Sci; 1964; 17():965-7. PubMed ID: 14246381
    [No Abstract]   [Full Text] [Related]  

  • 25. CERTAIN BASIC CONCEPTS CONCERNING THE TREATMENT OF THE EPILEPSIES.
    GASTAUT H
    Br J Clin Pract; 1964 Aug; 18():463-8. PubMed ID: 14206257
    [No Abstract]   [Full Text] [Related]  

  • 26. [Case of psychomotor epilepsy, probably of temporal origin; therapy by phenylacetylurea].
    MEIGNANT P; BARBIER J
    Rev Med Nancy; 1952 Jan 1-15; 77():33-9. PubMed ID: 14921354
    [No Abstract]   [Full Text] [Related]  

  • 27. [Phenyl-acetylurea in epilepsy therapy].
    SOREL L; COLLE J; D'HOLLANDER L
    Acta Neurol Psychiatr Belg; 1951 May; 51(5):309-18. PubMed ID: 14837711
    [No Abstract]   [Full Text] [Related]  

  • 28. [Phenacetylurea in epilepsy and personality disorders].
    EUZIERE J; PAGES P; LAFON R; PASSOUANT P; LATOUR H; LABAUGE R; PUECH P
    Sem Hop; 1950 Sep; 26(65):3424-35. PubMed ID: 14781900
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phenylethylacetylurea; general pharmacodynamic properties and comparison with other antiepileptics].
    GOLD P; FROMMEL E; RADOUCO C; GREDER G; MELKONIAN D; DELLA SANTA R; RADOUCO S; VALLETTE F; DUCOMMUN M
    Arch Int Pharmacodyn Ther; 1952 Sep; 91(3-4):437-60. PubMed ID: 13008524
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenacemide in treatment of epilepsy.
    TYLER MW; KING EQ
    J Am Med Assoc; 1951 Sep; 147(1):17-21. PubMed ID: 14861009
    [No Abstract]   [Full Text] [Related]  

  • 31. [Phenylacetylurea therapy in epilepsy].
    CENTINI D; RADICCHI M
    Rass Studi Psichiatr; 1952; 41(3):457-64. PubMed ID: 12983652
    [No Abstract]   [Full Text] [Related]  

  • 32. [First clinical experiences with a new phenuron derivative in therapy-resistant epileptics].
    KRAUSE G; FOERSTER W
    Psychiatr Neurol Med Psychol (Leipz); 1961 Jul; 13():270-3. PubMed ID: 13754081
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical tests of a new anti-epileptic drug: phenylacetylurea].
    FURTADO D
    J Med (Oporto); 1955 Dec; 28(671):727-36. PubMed ID: 13278123
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenylacetylurea in the treatment of convulsive seizures.
    CARTER S; SCIARRA D; MERRITT HH
    Dis Nerv Syst; 1950 May; 11(5):139-41. PubMed ID: 15411869
    [No Abstract]   [Full Text] [Related]  

  • 35. [Significance of the attack point of diphenylhydantoin, phenobarbital and the acylureas for our comprehension of the physiopathological mechanism of epilepsy].
    FROMMEL E; RADOUCO-THOMAS C
    Helv Physiol Pharmacol Acta; 1953; 11(2):231-8. PubMed ID: 13095893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemistry, pharmacology and therapeutic applications of phenylacetylurea, a new anti-epileptic substance].
    BERLINGOZZI S; MARRI R; CENTINI D; RADICCHI M; DI PACO G
    Minerva Med; 1952 Sep; 43(74):385-9. PubMed ID: 13012975
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hypoplastic myelosis in an epileptic woman treated with phenylacetylurea in combination with gardenal and benzedrine].
    BOUDIN G; NICK J; BARBIZET J; JOB JC
    Bull Mem Soc Med Hop Paris; 1952 May 23-30; 68(18-19):596-601. PubMed ID: 14954472
    [No Abstract]   [Full Text] [Related]  

  • 38. Fatal hepatitis after phenurone therapy for epilepsy.
    FIELD JB; JUSTI RA
    N Engl J Med; 1954 Jul; 251(4):147-9. PubMed ID: 13185386
    [No Abstract]   [Full Text] [Related]  

  • 39. [APROPOS OF LIVER DAMAGE DUE TO PROLONGED BARBITURATE AND HYDANTOIN THERAPY].
    SCHEDIFKA R
    Ther Ggw; 1964 Mar; 103():331-42. PubMed ID: 14189491
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hydantoins in the treatment of epilepsy].
    WEINLAND WL
    Nervenarzt; 1950 Mar; 21(3):119-24. PubMed ID: 15423635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.